New Treatments for Myelodysplastic Syndromes

Abstract

In the last decade, significant advances have been made in the treatment of patients with Myelodysplastic Syndromes (MDS). Although best supportive care continues to have an important role in the management of MDS, to date the therapeutic approach is diversified according to the IPSS risk group, karyotype, patient's age, comorbidities, and compliance… (More)
DOI: 10.4084/MJHID.2010.021

Topics

1 Figure or Table

Slides referencing similar topics